Literature DB >> 18662683

The effects of chronic intraperitoneal administration of the GABA B receptor agonist baclofen on food intake in rats.

Sunit M Patel1, Ivor S Ebenezer.   

Abstract

This study was undertaken to examine the effects of repeated administration of the GABA(B) receptor agonist baclofen on food intake in male Wistar rats. In the 1st Experiment, the effects of daily administration of physiological saline and baclofen (2 mg/kg, i.p.) for 27 days were investigated on food intake and body weight in non-deprived rats (n=6 in each group). Baclofen significantly (P<0.05) increased cumulative food intake each day over the treatment period during the 60 min measurement period following administration. Tolerance did not develop to the short-term hyperphagic effect of baclofen over the course of the experiment. In addition, treatment with baclofen did not alter body weight of the animals over the 27 day treatment period when compared with the saline control rats. In the 2nd Experiment, the effects of acute and chronic administration of baclofen (2 mg/kg) were investigated on 24 h food intake in rats. The rats were injected daily for 21 days with either saline (n=6) or baclofen (n=6). Food intake was measured in 30 min time bins for 24 h on treatment Days 1, 12 and 21 following injection. The results showed that while baclofen produced short-term increases in food consumption following injection on treatment Days 1, 12 and 21, the daily (24 h) food intake of the animals was not significantly different from those of control rats. Thus, these data reveal that while chronic administration of baclofen (2 mg/kg) produces short-term increases in feeding without the development of tolerance, daily (24 h) food consumption is not affected. These findings are consistent with the observation that chronic administration of baclofen (2 mg/kg) had no effect on the body weight of these animals.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18662683     DOI: 10.1016/j.ejphar.2008.07.018

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

1.  Baclofen, raclopride, and naltrexone differentially affect intake of fat/sucrose mixtures under limited access conditions.

Authors:  K J Wong; F H W Wojnicki; R L W Corwin
Journal:  Pharmacol Biochem Behav       Date:  2009-02-13       Impact factor: 3.533

2.  Fat emulsion composition alters intake and the effects of baclofen.

Authors:  Y Wang; D C Wilt; F H E Wojnicki; R K Babbs; J N Coupland; R L C Corwin
Journal:  Appetite       Date:  2011-08-10       Impact factor: 3.868

3.  Neuroendocrine response to GABA-B receptor agonism in alcohol-dependent individuals: Results from a combined outpatient and human laboratory experiment.

Authors:  Mehdi Farokhnia; Mikela B Sheskier; Mary R Lee; April N Le; Erick Singley; Sofia Bouhlal; Timmy Ton; Zhen Zhao; Lorenzo Leggio
Journal:  Neuropharmacology       Date:  2018-04-14       Impact factor: 5.250

4.  Baclofen suppresses binge eating of pure fat but not a sugar-rich or sweet-fat diet.

Authors:  Laura A Berner; Miriam E Bocarsly; Bartley G Hoebel; Nicole M Avena
Journal:  Behav Pharmacol       Date:  2009-10       Impact factor: 2.293

Review 5.  GABAergic signaling by AgRP neurons prevents anorexia via a melanocortin-independent mechanism.

Authors:  Qi Wu; Richard D Palmiter
Journal:  Eur J Pharmacol       Date:  2011-01-03       Impact factor: 4.432

Review 6.  Can We Selectively Reduce Appetite for Energy-Dense Foods? An Overview of Pharmacological Strategies for Modification of Food Preference Behavior.

Authors:  Ewa Bojanowska; Joanna Ciosek
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

7.  Role of leptin in the regulation of food intake in fasted mice.

Authors:  Tong Tong Ge; Xiao Xiao Yao; Feng Lian Zhao; Xiao Han Zou; Wei Yang; Ran Ji Cui; Bing Jin Li
Journal:  J Cell Mol Med       Date:  2020-03-15       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.